Teratogenic Effects of Maternal Medication Use During Pregnancy: A Comprehensive Review

Research Article

Authors

  • Okwah Micah Nnabuko Department of Chronic Disease Epidemiology, Yale University, Connecticut, United States Author
  • Akinrele Olaitan Rashidat Department of Clinical Sciences, Obafemi Awolowo University, Ile-ife, Osun state, Nigeria Author
  • Moses Adondua Abah Department of Biochemistry, Faculty of Biosciences, Federal University Wukari, Taraba State, Nigeria Author
  • Micheal Oladosu Abimbola Department of Biochemistry, Faculty of Basic Medical Sciences, University of Lagos, Lagos State, Nigeria Author
  • Aleshe Sikiru Olayinka Department of Biochemistry, Faculty of Basic Medical Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria, Nigeria Author
  • Okpanachi Nuhu Oyibo Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, Nigeria Author
  • Nnaemeka Jennifer Department of Chemistry, Faculty of Arts and Sciences, Prairie View A&M University, Texas. 77446. United States of America Author
  • Adetoyi Gbadebo Moses Department of Chemical Pathology and Immunology, Faculty of Basic Clinical Sciences, College of Health Sciences, University of America Author

Keywords:

Teratogens, Maternal Medication, Pregnancy, Birth Defects, Fetal Development, Medication Safety

Abstract

The use of medications during pregnancy is a complex issue, as the health of the mother and fetus must be carefully balanced. While medications are often necessary to manage chronic conditions, they can also pose risks to fetal development. Teratogenic effects, which result in birth defects or developmental abnormalities, are a significant concern. Many medications have been identified as potential teratogens, including certain anticonvulsants, antidepressants, and antihypertensives. The risk of teratogenic effects depends on various factors, including the type of medication, dosage, and timing of exposure during pregnancy. Understanding the teratogenic potential of maternal medication use is crucial for informed decision-making and optimal pregnancy outcomes. This comprehensive review aimed at providing an in-depth analysis of the current evidence on the teratogenic effects of maternal medication use during pregnancy. The risks associated with various classes of medications, including anticonvulsants, antidepressants, antihypertensives, and others, highlighting the specific teratogenic effects and the factors that influence these risks, such as dosage and timing of exposure were also discussed in this review. Challenges of balancing maternal health with fetal safety and provide guidance on informed decision-making and risk assessment were addressed. Furthermore, strategies for minimizing harm to the developing fetus, including medication optimization, dose adjustment, and close monitoring were elucidated. By synthesizing the existing literature, this review aimed at informing clinical practice and guide research directions, ultimately contributing to improved pregnancy outcomes and reduced risk of birth defects. Our analysis in this review highlighted the need for careful consideration of the potential teratogenic effects of maternal medication use and underscores the importance of collaborative decision-making between healthcare providers and pregnant women. This review provides a valuable resource for healthcare professionals, researchers, and expectant mothers seeking to navigate the complex issues surrounding medication use during pregnancy.

Downloads

Published

2026-06-26

Issue

Section

Articles